ML329 10 mg | Purity Not Available
TargetMol
ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.
More Information Supplier PageML329
Search Results
AN2718 10 mg | 98.89%
TargetMol
AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro. It inhibits leucyl-tRN/A synthetase (LeuRS) from molds and yeasts (IC50s = 2 and 4.2 μM for A. fumigatus and C. albicans LeuRS, respectively), blocking protein synthesis.
More Information Supplier PageAN2718
AN2718 25 mg | 98.89%
TargetMol
AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro. It inhibits leucyl-tRN/A synthetase (LeuRS) from molds and yeasts (IC50s = 2 and 4.2 μM for A. fumigatus and C. albicans LeuRS, respectively), blocking protein synthesis.
More Information Supplier PageAN2718
Selamectin 10 mg | Purity Not Available
TargetMol
Selamectin is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.
More Information Supplier PageSelamectin
Selamectin 100 mg | Purity Not Available
TargetMol
Selamectin is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.
More Information Supplier PageSelamectin
R-IMPP 5 mg | Purity Not Available
TargetMol
R-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.
More Information Supplier PageR-IMPP
R-IMPP 25 mg | Purity Not Available
TargetMol
R-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.
More Information Supplier PageR-IMPP
R-IMPP 10 mg | Purity Not Available
TargetMol
R-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.
More Information Supplier PageR-IMPP
AN2718 5 mg | 98.89%
TargetMol
AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro. It inhibits leucyl-tRN/A synthetase (LeuRS) from molds and yeasts (IC50s = 2 and 4.2 μM for A. fumigatus and C. albicans LeuRS, respectively), blocking protein synthesis.
More Information Supplier PageAN2718
AN2718 50 mg | 98.89%
TargetMol
AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro. It inhibits leucyl-tRN/A synthetase (LeuRS) from molds and yeasts (IC50s = 2 and 4.2 μM for A. fumigatus and C. albicans LeuRS, respectively), blocking protein synthesis.
More Information Supplier PageAN2718